Top 10 MedTech Conferences to Watch in 2026

As the MedTech landscape evolves—driven by advancements in AI, growing investor interest, and shifting regulatory expectations—choosing the right conferences to attend is more important than ever. Over the last several years, we’ve observed which events consistently bring together founders, investors, strategics, scientists, and regulatory leaders.

Below is a curated list of ten MedTech conferences to consider for 2026. This selection includes partnering forums, scientific meetings, investor-heavy gatherings, and operational summits that help innovators move faster and smarter.

1. J.P. Morgan Healthcare Conference & Partnering Forums

Dates: January 12–15, 2026 (jpmorgan.com)

  • For companies of all sizes, this event may appeal because it compresses months of investor outreach into a few days and allows direct access to strategic partners.

  • If you represent a consulting firm, attending is ideal for connecting with clients who need regulatory support, FDA meeting prep, or strategic advisory services.

  • Corporate innovators will benefit from benchmarking regulatory strategies and networking with peers entering the MedTech space.

2. LSX World Congress USA

Dates: September 15–16, 2026 (informaconnect.com)

  • If you’re an early-stage startup founder, this event may appeal because of its curated one-on-one sessions with investors and pharma partners to accelerate fundraising and strategic deals.

  • If you represent a consulting firm, it’s a great opportunity to meet emerging clients who may require FDA strategy, submission oversight, or regulatory guidance.

  • Corporate innovators can gain insight into market trends and identify potential collaboration opportunities.

3. HLTH (USA)

Dates: TBD November 2026 (hlth.com)

  • For companies of all sizes, this event may appeal because it offers insight into AI-enabled devices, digital health integration, and enterprise adoption to support scaling.

  • If you represent a consulting firm, attending provides visibility into emerging client needs around FDA compliance and digital health regulations.

  • Corporate innovators can explore partnerships with innovative startups and benchmark internal strategies against industry trends.

4. HLTH Europe

Dates: TBD 2026 (hlth.com)

  • For companies of all sizes, this event may appeal because it provides exposure to EU regulatory frameworks, CE marking, and reimbursement considerations for international expansion.

  • If you represent a consulting firm, it’s a valuable opportunity to observe EU-specific regulatory approaches and uncover advisory opportunities for clients.

  • Corporate innovators will find practical guidance on European market entry strategies and insights into regulatory compliance for new products.

5. ARVO Annual Meeting

Dates: TBD 2026 (arvo.org)

  • For companies of all sizes, this event may appeal because it offers access to cutting-edge ophthalmology research and clinical insights critical for FDA pre-submissions and trial design.

  • If you represent a consulting firm, attending allows you to engage investigators and deepen your understanding of evidence generation for client projects.

  • Corporate innovators can stay informed on ophthalmic device trends and spot early innovation opportunities.

6. The MedTech Conference (AdvaMed)

Dates: October 18–21, 2026 (themedtechconference.com)

  • For companies of all sizes, this event may appeal because it provides networking with regulators, investors, and industry leaders to support FDA strategy and market-entry planning.

  • If you represent a consulting firm, attending is ideal for connecting with prospective clients seeking submission support, regulatory memos, or fractional guidance.

  • Corporate innovators can gather insights on industry priorities, refine regulatory positioning, and evaluate strategic opportunities.

7. LSI Partnering Events

Dates: TBD 2026 (ls-intelligence.com)

  • If you’re an early-stage startup founder, this event may appeal because it delivers high-quality one-on-one sessions with investors and corporate partners, accelerating funding and regulatory execution.

  • If you represent a consulting firm, it’s a chance to engage clients who require tailored FDA strategy, submission oversight, or regulatory-on-demand services.

  • Corporate innovators can observe emerging companies and explore potential partnerships with high-growth startups.

8. MedTech World / MedTech Malta (MTW)

Dates: TBD 2026 (medtechworld.com)

  • If you’re an early-stage startup founder, this event may appeal because it provides international regulatory insights and guidance for cross-border market-entry strategies.

  • If you represent a consulting firm, attending offers a way to track global regulatory trends and identify potential advisory opportunities.

  • Corporate innovators will benefit from learning about cross-border regulations, global launch strategies, and fractional expert support for complex product entries.

9. DeviceTalks Boston

Dates: May 27–28, 2026 (boston.devicetalks.com)

  • For companies of all sizes, this event may appeal because it focuses on prototyping, scaling, and operational considerations tied to FDA submission readiness.

  • If you represent a consulting firm, attending helps identify startups needing regulatory guidance, quality support, or operational strategy.

  • Corporate innovators can gain insights on emerging device innovations and evaluate operational best practices.

10. Veeva MedTech Summit North America

Dates: TBD 2026 (veeva.com)

  • If you’re an early-stage startup founder, this event may appeal because it provides actionable insights into regulatory compliance, quality systems, and trial readiness for FDA submissions.

  • If you represent a consulting firm, attending helps refine service offerings and understand client regulatory needs.

  • Corporate innovators can engage in peer learning around FDA software guidance interpretation and high-level regulatory strategy.

Key Takeaways for 2026

Plan early: book meetings well in advance for investor-heavy or partnering events.

  • Prioritize by objectives: fundraising, BD, regulatory insight, clinical collaboration, or commercialization.

  • Balance global and local events: consider regional events like MedTech Malta or HLTH Europe for international expansion.

  • Prepare strategically: well-planned attendance and follow-up can create more value than simply showing up.

Previous
Previous

The Dual Brain Drain: How Recent Staffing Shifts at CDRH Threaten Medical Device Innovation

Next
Next

Navigating the MedTech Innovation Landscape: 7 Key Characteristics of a Successful Incubator or Accelerator